Across TCGA pan-cancer cohorts, LINC02583 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02583’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC02583 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02583 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRP, HNSC, and BRCA are the cancer types where LINC02583 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02583 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	III,IV	+0.013	.045	2	view →
HNSC	All	All	+0.197	.027	1	view →
BRCA	All	All	+0.036	.047	1	view →
THCA	Female	All	−0.011	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC02583 RNA expression & survival · all LINC02583 data types